{"meshTagsMajor":["Mutation"],"meshTags":["Antineoplastic Agents","Piperazines","Humans","Imatinib Mesylate","Proto-Oncogene Proteins c-kit","Benzamides","Mutation","Pyrimidines","Melanoma"],"meshMinor":["Antineoplastic Agents","Piperazines","Humans","Imatinib Mesylate","Proto-Oncogene Proteins c-kit","Benzamides","Pyrimidines","Melanoma"],"publicationTypes":["Comment","Letter"],"title":"Imatinib in melanoma: a selective treatment option based on KIT mutation status?","pubmedId":"17327598"}